Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nivolumab plus paclitaxel in biomarker-selected advanced gastric cancer
KCT0004186Phase 2Completed
- Sponsor
- Ono Pharmaceutical
- Start
- Feb 2018
- Modality
- Small Molecules, Monoclonal Antibodies → Antibody-Based Therapeutics
- Countries
- 1
01
Overview
A Phase 2 trial of nivolumab, paclitaxel in gastric cancer (GC), sponsored by Ono Pharmaceutical. Started Feb 2018; status: completed.
02
Drugs
nivolumabpaclitaxel
03
Conditions
gastric cancer (GC)
Beyond the preview
Go deeper on KCT0004186.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0004186.